Energy metabolism targeted drugs synergize with photodynamic therapy to potentiate breast cancer cell death (Q38943330)

7 September 2017

title

Energy metabolism targeted drugs synergize with photodynamic therapy to potentiate breast cancer cell death (English)

1 reference

7 September 2017

1 reference

Xiaolan Feng

1

1 reference

7 September 2017

Yi Zhang

2

1 reference

7 September 2017

Pan Wang

3

1 reference

7 September 2017

Quanhong Liu

4

1 reference

7 September 2017

Xiaobing Wang

5

1 reference

7 September 2017

publication date

3 November 2014

1 reference

Photochemical and Photobiological Sciences

7 September 2017

published in

1 reference

7 September 2017

volume

13

1 reference

7 September 2017

issue

12

1 reference

7 September 2017

page(s)

1793-1803

1 reference

Metabolic alterations in cancer cells and therapeutic implications

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Metabolic targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Anticancer agents that counteract tumor glycolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Cancer as a metabolic disease: implications for novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Glycolysis inhibition for anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Photodynamic therapy of cancer: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Biomodulatory approaches to photodynamic therapy for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

How mainstream medicine sees photodynamic therapy in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Comparisons among sensitivities of different tumor cells to focused ultrasound in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Apoptosis induced by sonodynamic treatment by protoporphyrin IX on MDA-MB-231 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Light-Activated Pharmaceuticals: Mechanisms and Detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

p38(MAPK)-regulated induction of p62 and NBR1 after photodynamic therapy promotes autophagic clearance of ubiquitin aggregates and reduces reactive oxygen species levels by supporting Nrf2-antioxidant signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Targeting the latest hallmark of cancer: another attempt at 'magic bullet' drugs targeting cancers' metabolic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Ultrasound enhances the efficacy of chlorin E6-mediated photodynamic therapy in MDA-MB-231 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Solution structure of the antiapoptotic protein bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Emerging roles of caspase-3 in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Differential effects of glucose deprivation on the cellular sensitivity towards photodynamic treatment-based production of reactive oxygen species and apoptosis-induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Stress-responsive protein kinases in redox-regulated apoptosis signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

From death receptor to reactive oxygen species and c-Jun N-terminal protein kinase: the receptor-interacting protein 1 odyssey

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

High concentrations of ascorbic acid induces apoptosis of human gastric cancer cell by p38-MAP kinase-dependent up-regulation of transferrin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Differential cytotoxicity of the glycolytic inhibitor 2-deoxy-D-glucose in isogenic cell lines varying in their p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Endoplasmic reticulum stress induced by 2-deoxyglucose but not glucose starvation activates AMPK through CaMKKβ leading to autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

2-Deoxy-D-glucose treatment of endothelial cells induces autophagy by reactive oxygen species-mediated activation of the AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4PP00288A

21 January 2018

Identifiers

DOI

10.1039/C4PP00288A

1 reference

7 September 2017

1 reference